Back to DE D. E. Shaw & Co., Inc.
PRPRAX
Showing 0 of 6 quarters
Position history for DED. E. Shaw & Co., Inc.'s holdings in Praxis Precision Medicines, Inc.
No. D. E. Shaw exited its PRAX (Praxis Precision Medicines) position in Q1 2023. Its Q4 2022 13F listed 574,426 shares worth $1.4M. D. E. Shaw first reported PRAX in Q2 2021 and held it in 4 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.